WASHINGTON, Jul 9 (Alliance News): More than 2.5 million bottles of prescription eye drops have been recalled across the United States after the US Food and Drug Administration (FDA) identified possible contamination with a foreign substance.
The voluntary recall involves Prednisolone Acetate Ophthalmic Suspension USP 1%, manufactured by Lupin Pharmaceuticals Inc. The FDA classified the action as a Class II recall, indicating that use of the affected product may cause temporary or medically reversible health problems.
The recalled medicine is commonly prescribed to reduce redness, itching and inflammation, particularly following eye surgery.
According to the FDA, the recall covers 2,530,182 bottles in three package sizes: 5 ml, 10 ml and 15 ml.
Consumers are advised to check both the National Drug Code (NDC) and the lot number on their bottles. The affected products include 5 ml bottles (NDC 70748-332-02), 10 ml bottles (NDC 70748-332-03) and 15 ml bottles (NDC 70748-332-04) with lot numbers beginning with HA, HB or HC.
Health authorities have advised patients not to stop using prescribed steroid eye drops without first consulting their healthcare provider, as sudden discontinuation may lead to complications related to eye inflammation.
Patients with recalled products should contact their doctor or pharmacist to obtain a replacement from an unaffected batch or discuss alternative treatment options.
